CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. (6th December 2016) - Pignolet, Béatrice; Schwab, Nicholas; Schneider-Hohendorf, Tilman; Bucciarelli, Florence; Biotti, Damien; Averseng-Peaureaux, Delphine; Outteryck, Olivier; Ongagna, Jean-Claude; de Sèze, Jérôme; Brochet, Bruno; Ouallet, Jean-Christophe; Debouverie, Marc; et al.